Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples